Balyasny Asset Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20,811	Closed	-$221K	–	2003
2018 Q1	$221K	Buy	20,811 +17,461	+521%	+$185K	﹤0.01%	1535
2017 Q4	$141K	Sell	3,350 -4,275	-56%	-$180K	﹤0.01%	1704
2017 Q3	$420K	Buy	+7,625	New	+$420K	﹤0.01%	1208